Cancer ResearchHealthScience & Technology
Arch Oncology in St. Louis Develops Innovative Cancer-Killing Technology for Antibody Therapy
Arch Oncology is advancing its unique cancer-killing antibody therapies in clinical trials.
Cancer ResearchScience & Technology
St. Louis Bioscience in the Spotlight as BioGenerator Portfolio Tops $2 Billion in Follow-On Capital
BioGenerator Ventures portfolio has raised $2.2 billion in follow-on capital, with much of the success involving one company in 2021.
Novel Cancer Drug by St. Louis Startup Is Designed to Uniquely Destroy Tumors Throughout Body
Immunophotonics announced it has raised $21.4 million dollars to advance clinical trials of its cancer treatment.
St. Louis biotech startup Wugen is advancing novel cellular therapies to treat cancer
If Wugen is not working on its memory natural killer cell technology, it’s not top secret that Wugen has ‘007.’
President Biden’s Cancer Moonshot is Expected to Fund Innovative Treatments in St. Louis
Federal dollars from Cancer Moonshot is expected to help companies develop innovative cancer treatments and diagnostics in St. Louis.
Zika Virus Helps Destroy Deadly Brain Cancer in Mice, Offering Hope for New Glioblastoma Treatment
Zika virus gives a powerful boost to immunotherapy, effectively destroying deadly brain cancer in lab mice.
New Brain Tumor Center at Siteman Cancer Center to be Part of Neuroscience Research Building
The newly formed Brain Tumor Center is part of Siteman Cancer Center and the Washington University Medical Campus in St. Louis.
St. Louis-Based Geneoscopy is Having Success with At-Home Colorectal Cancer Screening Tests
Geneoscopy wants to improve widespread colorectal cancer detection and prevention through participation with at-home collection kits.
Siteman Cancer Center Expands To China
World Trade Center St. Louis established a connection for an expansion of the Siteman Cancer Center to Shouzou, China.
New Breakthroughs In Lighting Up Cancer Cells To Find And Destroy Cancer
New research successfully uses light as a precision weapon against cancer by creating an army of light-triggered nanoparticles to lead the attack.